334 related articles for article (PubMed ID: 21903285)
1. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.
Li JL; Ji JF; Cai Y; Li XF; Li YH; Wu H; Xu B; Dou FY; Li ZY; Bu ZD; Wu AW; Tham IW
Radiother Oncol; 2012 Jan; 102(1):4-9. PubMed ID: 21903285
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
Freedman GM; Meropol NJ; Sigurdson ER; Hoffman J; Callahan E; Price R; Cheng J; Cohen S; Lewis N; Watkins-Bruner D; Rogatko A; Konski A
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1389-93. PubMed ID: 17394942
[TBL] [Abstract][Full Text] [Related]
3. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial.
Ballonoff A; Kavanagh B; McCarter M; Kane M; Pearlman N; Nash R; Shah RJ; Raben D; Schefter TE
Am J Clin Oncol; 2008 Jun; 31(3):264-70. PubMed ID: 18525306
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
6. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.
Arbea L; Martínez-Monge R; Díaz-González JA; Moreno M; Rodríguez J; Hernández JL; Sola JJ; Ramos LI; Subtil JC; Nuñez J; Chopitea A; Cambeiro M; Gaztañaga M; García-Foncillas J; Aristu J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):587-93. PubMed ID: 22079731
[TBL] [Abstract][Full Text] [Related]
7. Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial).
Veerasarn V; Phromratanapongse P; Lorvidhaya V; Lertsanguansinchai P; Lertbutsayanukul C; Panichevaluk A; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Rojanasakul A; Thavichaigarn P; Jivapaisarnpong P
J Med Assoc Thai; 2006 Nov; 89(11):1874-84. PubMed ID: 17205868
[TBL] [Abstract][Full Text] [Related]
8. Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma.
Stojanovic S; Popov I; Radosevic-Jelic L; Micev M; Borojevic N; Nikolic V; Krivokapic Z; Kecmanovic D; Gavrilovic D; Kezic I
Cancer Chemother Pharmacol; 2011 Sep; 68(3):787-93. PubMed ID: 21188380
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer.
Park JH; Yoon SM; Yu CS; Kim JH; Kim TW; Kim JC
Cancer; 2011 Aug; 117(16):3703-12. PubMed ID: 21328328
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
Krishnan S; Janjan NA; Skibber JM; Rodriguez-Bigas MA; Wolff RA; Das P; Delclos ME; Chang GJ; Hoff PM; Eng C; Brown TD; Crane CH; Feig BW; Morris J; Vadhan-Raj S; Hamilton SR; Lin EH
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):762-71. PubMed ID: 17011451
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer.
Zampino MG; Magni E; Leonardi MC; Petazzi E; Santoro L; Luca F; Chiappa A; Petralia G; Trovato C; Fazio N; Orecchia R; Nolè F; de Braud F
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):421-7. PubMed ID: 19211200
[TBL] [Abstract][Full Text] [Related]
12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
13. Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer.
Kim JC; Kim TW; Kim JH; Yu CS; Kim HC; Chang HM; Ryu MH; Park JH; Ahn SD; Lee SW; Shin SS; Kim JS; Choi EK
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):346-53. PubMed ID: 15913913
[TBL] [Abstract][Full Text] [Related]
14. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].
Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010
[TBL] [Abstract][Full Text] [Related]
15. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Vestermark LW; Jensen HA; Pfeiffer P
Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.
Velenik V; Ocvirk J; Oblak I; Anderluh F
Eur J Surg Oncol; 2010 Mar; 36(3):244-50. PubMed ID: 20042310
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine.
Ramani VS; Sun Myint A; Montazeri A; Wong H
Colorectal Dis; 2010 Aug; 12 Suppl 2():37-46. PubMed ID: 20618366
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.
Desai SP; El-Rayes BF; Ben-Josef E; Greenson JK; Knol JA; Huang EH; Griffith KA; Philip PA; McGinn CJ; Zalupski MM
Am J Clin Oncol; 2007 Aug; 30(4):340-5. PubMed ID: 17762432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]